[go: up one dir, main page]

SV2002000601A - Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados - Google Patents

Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados

Info

Publication number
SV2002000601A
SV2002000601A SV2001000601A SV2001000601A SV2002000601A SV 2002000601 A SV2002000601 A SV 2002000601A SV 2001000601 A SV2001000601 A SV 2001000601A SV 2001000601 A SV2001000601 A SV 2001000601A SV 2002000601 A SV2002000601 A SV 2002000601A
Authority
SV
El Salvador
Prior art keywords
aril
derivatives
manufacture
antranilic
acids
Prior art date
Application number
SV2001000601A
Other languages
English (en)
Spanish (es)
Inventor
Chen Michael Huai Gu
Davis Edward Mark
Javier Magano
Thomas Norman Nanninga
Derick Dale Winkle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SV2002000601A publication Critical patent/SV2002000601A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
SV2001000601A 2000-08-25 2001-08-15 Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados SV2002000601A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22820600P 2000-08-25 2000-08-25

Publications (1)

Publication Number Publication Date
SV2002000601A true SV2002000601A (es) 2002-04-03

Family

ID=22856235

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2001000601A SV2002000601A (es) 2000-08-25 2001-08-15 Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados

Country Status (31)

Country Link
EP (1) EP1313694A1 (is)
JP (1) JP2004507518A (is)
KR (1) KR20030059115A (is)
CN (1) CN1458921A (is)
AP (1) AP2001002249A0 (is)
AR (1) AR032175A1 (is)
AU (1) AU2001277044A1 (is)
BG (1) BG107635A (is)
BR (1) BR0113520A (is)
CA (1) CA2420003A1 (is)
CZ (1) CZ2003477A3 (is)
DO (1) DOP2001000238A (is)
EA (1) EA200300187A1 (is)
GT (1) GT200100174A (is)
HN (1) HN2001000216A (is)
HU (1) HUP0300828A2 (is)
IL (1) IL154507A0 (is)
IS (1) IS6724A (is)
MA (1) MA26949A1 (is)
MX (1) MXPA03001654A (is)
NO (1) NO20030844L (is)
PA (1) PA8526501A1 (is)
PE (1) PE20020393A1 (is)
PL (1) PL360699A1 (is)
SK (1) SK2072003A3 (is)
SV (1) SV2002000601A (is)
TN (1) TNSN01127A1 (is)
UY (1) UY26908A1 (is)
WO (1) WO2002018319A1 (is)
YU (1) YU14303A (is)
ZA (1) ZA200301182B (is)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235537B2 (en) 2002-03-13 2007-06-26 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as MEK inhibitors
PA8569301A1 (es) 2002-03-13 2004-10-08 Array Biopharma Inc "derivados de bencimidazol n3 alquilado como inhibidores de mek" "n3 alkylated benzimidazole derivatives as mek inhibitors"
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7538120B2 (en) 2003-09-03 2009-05-26 Array Biopharma Inc. Method of treating inflammatory diseases
RU2352558C2 (ru) 2003-10-21 2009-04-20 Уорнер-Ламберт Компани Ллс Полиморфная форма n-[(r)-2,3-дигидроксипропокси]-3,4-дифтор-2-(2-фтор-4 йодфениламино)бензамида
US7732616B2 (en) 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
US7517994B2 (en) 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
BRPI0416692A (pt) 2003-11-19 2007-01-30 Array Biopharma Inc inibidores heterocìclicos de mek e métodos de emprego destes
US20050130954A1 (en) 2003-11-21 2005-06-16 Mitchell Ian S. AKT protein kinase inhibitors
UA89035C2 (ru) * 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
PT1877379E (pt) 2005-04-13 2013-04-17 Astex Therapeutics Ltd Derivados de hidroxibenzamida e seu uso como inibidores de hsp90
EP1967516B1 (en) 2005-05-18 2009-11-04 Array Biopharma, Inc. 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as MEK inhibitors for the treatment of hyperproliferative diseases
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
JP5231411B2 (ja) 2006-07-06 2013-07-10 アレイ バイオファーマ、インコーポレイテッド Aktプロテインキナーゼ阻害剤としてのジヒドロチエノピリミジン
DE602007011628D1 (de) 2006-07-06 2011-02-10 Array Biopharma Inc Dihydrofuropyrimidine als akt-proteinkinaseinhibitoren
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
MX2008016203A (es) 2006-07-06 2009-01-27 Array Biopharma Inc Ciclopenta [d] pirimidinas como inhibidores de la proteina cinasa akt.
EP2073802A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
JP5410285B2 (ja) 2006-10-12 2014-02-05 アステックス、セラピューティックス、リミテッド 医薬化合物
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
US9730912B2 (en) 2006-10-12 2017-08-15 Astex Therapeutics Limited Pharmaceutical compounds
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
KR101624361B1 (ko) 2007-07-05 2016-05-25 어레이 바이오파마 인크. Akt 단백질 키나제 억제제로서의 피리미딜 시클로펜탄
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
CA2692502C (en) 2007-07-05 2016-03-01 Array Biopharma Inc. Pyrimidyl cyclopentanes as akt protein kinase inhibitors
EP2247578B1 (en) 2008-01-09 2013-05-22 Array Biopharma, Inc. Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
NZ586720A (en) 2008-01-09 2012-11-30 Array Biopharma Inc Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CN101985428B (zh) * 2009-07-29 2014-02-12 杭州民生药业有限公司 邻苯胺基苯甲酸衍生物或其药学上可接受的盐、其制备方法及其用途
US20120316337A1 (en) * 2010-02-19 2012-12-13 Universite Du Maine Method for preparing chemical compounds of interest by nucleophilic aromatic substitution of aromatic carboxylic acid derivatives supporting at least one electro-attractive group
JP2013519715A (ja) * 2010-02-19 2013-05-30 センター ナショナル デ ラ リシェルシェ サイエンティフィック 少なくとも1つの電子求引性基を有する芳香族カルボン酸誘導体の芳香族求核置換による目的の化学化合物の調製方法
MY179607A (en) 2011-04-01 2020-11-11 Genentech Inc Combinations of akt inhibitor compounds and abiraterone, and methods of use
BR112013025397A2 (pt) 2011-04-01 2019-09-24 Deepak Sampath combinação de um composto, composto de fórmula i ou um sal farmaceuticamente aceitável do mesmo, uso, kit, produto, método para tratamento de um distúrbio hiperproliferativo e método para tratamento de uma doença ou afecção modulada por quinase akt em um mamífero
CN104837826B (zh) * 2012-10-12 2018-07-27 埃克塞里艾克西斯公司 制备用于治疗癌症的化合物的新型方法
CN112745237B (zh) * 2019-10-29 2023-06-20 中国科学院上海药物研究所 2-芳基胺类化合物及其制备方法和应用
WO2024011559A1 (en) * 2022-07-15 2024-01-18 Southern University Of Science And Technology Fused aromatic amine preparing from isocyanide and cyclopropene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
WO1998037881A1 (en) * 1997-02-28 1998-09-03 Warner Lambert Company Method of treating or preventing septic shock by administering a mek inhibitor
HUP0003731A3 (en) * 1997-07-01 2002-11-28 Warner Lambert Co 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
EP0993437B1 (en) * 1997-07-01 2006-11-08 Warner-Lambert Company Llc 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors
CA2348236A1 (en) * 1999-01-13 2000-07-20 Stephen Douglas Barrett 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
HK1045682B (zh) * 1999-04-21 2006-04-07 沃尼尔‧朗伯公司 制备-2-(n-苯基氨基)苯甲酸衍生物的方法

Also Published As

Publication number Publication date
CA2420003A1 (en) 2002-03-07
MA26949A1 (fr) 2004-12-20
EP1313694A1 (en) 2003-05-28
YU14303A (sh) 2006-08-17
CN1458921A (zh) 2003-11-26
PL360699A1 (en) 2004-09-20
MXPA03001654A (es) 2004-09-10
PA8526501A1 (es) 2002-07-30
KR20030059115A (ko) 2003-07-07
SK2072003A3 (en) 2004-01-08
NO20030844L (no) 2003-02-25
NO20030844D0 (no) 2003-02-24
IL154507A0 (en) 2003-09-17
DOP2001000238A (es) 2003-01-31
CZ2003477A3 (cs) 2003-10-15
AU2001277044A1 (en) 2002-03-13
EA200300187A1 (ru) 2003-08-28
PE20020393A1 (es) 2002-05-09
HUP0300828A2 (hu) 2003-09-29
BG107635A (bg) 2004-09-30
TNSN01127A1 (en) 2005-11-10
AP2001002249A0 (en) 2001-09-30
ZA200301182B (en) 2004-05-12
JP2004507518A (ja) 2004-03-11
WO2002018319A1 (en) 2002-03-07
GT200100174A (es) 2002-07-18
IS6724A (is) 2003-02-20
BR0113520A (pt) 2003-06-24
UY26908A1 (es) 2001-11-30
AR032175A1 (es) 2003-10-29
HN2001000216A (es) 2002-05-22

Similar Documents

Publication Publication Date Title
SV2002000601A (es) Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados
HN1999000072A (es) Preparaciones farmaceuticas estabilizadas de gaba pentina y proceso para prepararla.
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
HN1997000110A (es) Derivados del acido arilsulfoonilamino hidroxamico
BR0115482A (pt) Composição de sacralose melhorada e processo para sua preparação
DOP2001000224A (es) Composiciones farmaceuticas de inhibidores de la proteina de transferencia de colesteril ester.
HN1999000131A (es) Derivados del acido hidroxi pipecolato hidroxamico.
PA8469401A1 (es) Derivados biciclicos del acido hidroxamico
HN2003000038A (es) Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico
ES2166051T3 (es) Productos intermedios y procedimiento para preparar olanzapina.
SV2003000741A (es) Compuesto lactamico x-13170
DE60129032D1 (de) Creatinester-pronutrient-verbindungen und formulierungen
AR028078A1 (es) Proceso para la produccion de grrnulos de enzimas
ES2173399T3 (es) Procedimiento para la sintesis de benzotiofenos.
IS6799A (is) Bætt aðferð við framleiðslu á milliefni gabapentíns
IT1317073B1 (it) Esteri dell'acido fenilbutirrico, procedimenti per la loro produzionee loro impiego terapeutico.
CY1105526T1 (el) Διαδικασια συνθεσης και ενδιαμεσα της πυριδιν-2-υλ-μεθυναμινης
IS5019A (is) Aðferð til framleiðslu á hýdroxamsýrum
PT1339703E (pt) Processo para a preparacao de paclitaxel
CR6904A (es) Proceso para la fabricacion de acidos n-aril-antranilicos y sus derivados
HN1999000042A (es) Procedimiento para la preparacion de acidos hidroxamicos
GT199800192A (es) Procedimiento para la preparacion de acidos 8-metoxiquinoloncarboxilicos.
BRPI0113727B8 (pt) Processo para a produção de halo-4-fenoxiquinolinas.
AR027751A1 (es) Proceso para la n-formilacion selectiva de n-hidroxilaminas
EE05155B1 (et) Meetod optiliselt aktiivsete antratskliinide snteesimiseks

Legal Events

Date Code Title Description
FD Lapse